Literature DB >> 34994351

Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19.

Steven G Rothrock1,2, Kurt D Weber3, Philip A Giordano3, Mitchell D Barneck3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34994351     DOI： 10.1097/MJT.0000000000001461

Source DB:  PubMed          Journal:  Am J Ther        ISSN： 1075-2765            Impact factor:   2.688


× No keyword cloud information.
  3 in total

Review 1.  Ivermectin for preventing and treating COVID-19.

Authors:  Maria Popp; Stefanie Reis; Selina Schießer; Renate Ilona Hausinger; Miriam Stegemann; Maria-Inti Metzendorf; Peter Kranke; Patrick Meybohm; Nicole Skoetz; Stephanie Weibel
Journal:  Cochrane Database Syst Rev       Date:  2022-06-21

2.  Increasing incidence of reported scabies infestations in the Netherlands, 2011-2021.

Authors:  Babette van Deursen; Mariëtte Hooiveld; Susan Marks; Ingrid Snijdewind; Hans van den Kerkhof; Bas Wintermans; Ben Bom; Barbara Schimmer; Ewout Fanoy
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

3.  Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients.

Authors:  Arman Shafiee; Mohammad Mobin Teymouri Athar; Omid Kohandel Gargari; Kyana Jafarabady; Sepehr Siahvoshi; Sayed-Hamidreza Mozhgani
Journal:  Virol J       Date:  2022-06-13       Impact factor: 5.913
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.